West Chester, PA, United States of America

Louis V LaFrance


Average Co-Inventor Count = 10.2

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Louis V LaFrance

Introduction

Louis V LaFrance is an accomplished inventor based in West Chester, PA. He holds a total of four patents, showcasing his contributions to the field of pharmaceuticals and medicinal chemistry. His work primarily focuses on novel compounds that have significant therapeutic potential.

Latest Patents

One of his latest patents is titled "Substituted indoles and their use as integrin antagonists." This invention relates to novel substituted indole compounds that act as antagonists of alpha V integrins. These compounds may be utilized in treating various pathological conditions, including tumor growth, metastasis, and rheumatoid arthritis. Another significant patent is "Substituted 1,4-diazepines and uses thereof." This invention is directed towards novel 1,4-diazepines that serve as inhibitors of HDM2-p53 interactions, which are crucial in cancer therapy.

Career Highlights

Throughout his career, LaFrance has worked with notable companies such as Dimensional Pharmaceuticals, Inc. and 3-Dimensional Pharmaceutical, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

LaFrance has collaborated with professionals like Juan J Marugan Sanchez and Kristi A Leonard. These partnerships have likely enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Louis V LaFrance is a notable inventor whose work in pharmaceutical innovations has the potential to impact various medical conditions significantly. His contributions through patents reflect his dedication to advancing medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…